AAAAAA
Results:
1-8
|
Results: 8
Authors:
Ploeger, B
Mensinga, T
Sips, A
Seinen, W
Meulenbelt, J
DeJongh, J
Citation: B. Ploeger et al., The pharmacokinetics of glycyrrhizic acid evaluated by physiologically based pharmacokinetic modeling, DRUG METAB, 33(2), 2001, pp. 125-147
Authors:
Ploeger, B
Mensinga, T
Sips, A
Deerenberg, C
Meulenbelt, J
DeJongh, J
Citation: B. Ploeger et al., A population physiologically based pharmacokinetic/pharmacodynamic model for the inhibition of 11-beta-hydroxysteroid dehydrogenase activity by glycyrrhetic acid, TOX APPL PH, 170(1), 2001, pp. 46-55
Authors:
Ploeger, B
Mensinga, T
Sips, A
Meulenbelt, J
DeJongh, J
Citation: B. Ploeger et al., A human physiologically-based model for glycyrrhzic acid, a compound subject to presystemic metabolism and enterohepatic cycling, PHARM RES, 17(12), 2000, pp. 1516-1525
Authors:
Boereboom, FTJ
Ververs, FFT
Meulenbelt, J
van Dijk, A
Citation: Ftj. Boereboom et al., Hemoperfusion is ineffectual in severe chloroquine poisoning, CRIT CARE M, 28(9), 2000, pp. 3346-3350
Authors:
Ververs, TFT
van Dijk, A
Vinks, SATMM
Blankestijn, PJ
Savelkoul, TJF
Meulenbelt, J
Boereboom, FTJ
Citation: Tft. Ververs et al., Pharmacokinetics and dosing regimen of meropenem in critically ill patients receiving continuous venovenous hemofiltration, CRIT CARE M, 28(10), 2000, pp. 3412-3416
Authors:
Ploeger, BA
Meulenbelt, J
DeJongh, J
Citation: Ba. Ploeger et al., Physiologically based pharmacokinetic modeling of glycyrrhizic acid, a compound subject to presystemic metabolism and enterohepatic cycling, TOX APPL PH, 162(3), 2000, pp. 177-188
Authors:
Olling, M
Mensinga, TT
Barends, DM
Groen, C
Lake, OA
Meulenbelt, J
Citation: M. Olling et al., Bioavailability of carbamazepine from four different products and the occurrence of side effects, BIOPHARM DR, 20(1), 1999, pp. 19-28
Authors:
Meulenbelt, J
Mensinga, TT
Kortboyer, JM
Speijers, GJA
de Vries, I
Citation: J. Meulenbelt et al., Healthy volunteer studies in toxicology, TOX LETT, 103, 1998, pp. 35-39
Risultati:
1-8
|